Published in Blood Weekly, March 24th, 1997
"Initiation of this clinical trial represents an important advancement in the development of the Aastrom CPS. This trial is designed to demonstrate the ability of Aastrom CPS produced stem cells to reduce the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.